BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-190@pharmaconomics
DTSTAMP:20260707T034541Z
DTSTART;VALUE=DATE:20261222
DTEND;VALUE=DATE:20261223
SUMMARY:MLYS PDUFA — lorundrostat
DESCRIPTION:The FDA's approval decision on lorundrostat for hypertension is due Dec 22\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1933414/000193341426000048/mlys-20260306.htm\n\nTrack it: https://www.pharmaconomics.com/e/190
URL:https://www.pharmaconomics.com/e/190
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:MLYS catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR